Terms: = Kidney tumors AND COL1A1, P02452, 1277, ENSG00000108821, OI4 AND Prognosis
5 results:
1. A construction and comprehensive analysis of ceRNA networks and infiltrating immune cells in papillary renal cell carcinoma.
Fan Y; Dai F; Yuan M; Wang F; Wu N; Xu M; Bai Y; Liu Y
Cancer Med; 2021 Nov; 10(22):8192-8209. PubMed ID: 34598322
[TBL] [Abstract] [Full Text] [Related]
2. COL5A2 as a potential clinical biomarker for gastric cancer and renal metastasis.
Ding YL; Sun SF; Zhao GL
Medicine (Baltimore); 2021 Feb; 100(7):e24561. PubMed ID: 33607786
[TBL] [Abstract] [Full Text] [Related]
3. Overexpressed pseudogenes, DUXAP8 and DUXAP9, promote growth of renal cell carcinoma and serve as unfavorable prognostic biomarkers.
Chen J; Lou W; Ding B; Wang X
Aging (Albany NY); 2019 Aug; 11(15):5666-5688. PubMed ID: 31409759
[TBL] [Abstract] [Full Text] [Related]
4. Molecular pathogenesis of renal cell carcinoma: Impact of the anti-tumor miR-29 family on gene regulation.
Yamada Y; Sugawara S; Arai T; Kojima S; Kato M; Okato A; Yamazaki K; Naya Y; Ichikawa T; Seki N
Int J Urol; 2018 Nov; 25(11):953-965. PubMed ID: 30153702
[TBL] [Abstract] [Full Text] [Related]
5. The benefits of cancer screening in kidney transplant recipients: a single-center experience.
Kato T; Kakuta Y; Abe T; Yamanaka K; Imamura R; Okumi M; Ichimaru N; Takahara S; Nonomura N
Cancer Med; 2016 Feb; 5(2):153-8. PubMed ID: 26686199
[TBL] [Abstract] [Full Text] [Related]
